Cargando…
SOD2 genetic variant associated with treatment-related ototoxicity in cisplatin-treated pediatric medulloblastoma
Manganese superoxide dismutase (MnSOD), encoded by the SOD2 gene, is involved in the detoxification of superoxide anion. Superoxide is likely a source of oxidative stress in the cochlea following treatment with platinum agents and radiation. Therefore, we examined SOD2 variants in association with o...
Autores principales: | Brown, Austin L, Lupo, Philip J, Okcu, Mehmet Fatih, Lau, Ching C, Rednam, Surya, Scheurer, Michael E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673994/ https://www.ncbi.nlm.nih.gov/pubmed/26400460 http://dx.doi.org/10.1002/cam4.516 |
Ejemplares similares
-
Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy
por: Moeller, Benjamin J, et al.
Publicado: (2011) -
Cisplatin ototoxicity histopathology
por: Hodge, Sarah E., et al.
Publicado: (2021) -
The Effect of Dexpanthenol on Ototoxicity Induced by Cisplatin
por: Toplu, Yuksel, et al.
Publicado: (2016) -
The Role of Thiamine Pyrophosphate in Prevention of Cisplatin Ototoxicity in an Animal Model
por: Kuduban, Ozan, et al.
Publicado: (2013) -
The effect of genistein on cisplatin induced ototoxicity and oxidative stress
por: Tan, Mehmet, et al.
Publicado: (2021)